In May, state and town officials announced that Genentech, a global leader in biotechnology, has chosen the CaMP Helix innovation campus for a $700 million investment that will add to the ongoing economic and professional transformation of our area as a premier life sciences hub.
The new 700,000-square-foot facility will be Genentech’s first East Coast manufacturing site. The plant will specialize in the fill-finish stage of drug manufacturing and primarily support next-generation metabolic and obesity medications, positioning Holly Springs at the forefront of cutting-edge pharmaceutical production.
Locating at CaMP Helix is intentional, of course. The 400-acre campus was designed with biotech in mind, offering robust infrastructure, readily available utilities, and a master plan that supports long-term growth. Future road improvements and a planned U.S. 1 interchange will ensure that the area keeps pace with the scale of development. In addition to its business appeal, the campus location reinforces Holly Springs’ commitment to balancing economic opportunity with community connectivity. Easy access to NC-540, Raleigh-Durham International Airport, and Research Triangle Park make it an ideal place for Genentech to join current industry leaders Amgen, Fujifilm Diosynth Biotechnologies, and CSL Seqirus. Also worth noting is the campus proximity to Wake Technical Community College. This provides a key advantage for workforce development, ensuring a steady channel of skilled talent looking to call Holly Springs home for years to come.
Genentech is expected to fill more than 400 high-paying jobs over the next decade, not to mention creating approximately 1,500 construction jobs even before the facility opens its doors as the first phases of development begin in coming months. While the building won’t be fully operational until the end of 2030, Genentech plans to ramp up hiring between 2028 and 2032, introducing permanent jobs in manufacturing, quality assurance, and operations. What a boost to the local economy!
Mayor Sean Mayefski described the announcement as “a transformative moment for Holly Springs.” He added, “Genentech is a perfect fit for our innovation ecosystem, and their investment will benefit our community for generations.”
Not surprisingly, while many residents are excited about the announcement, development of this magnitude also prompts discussion about sustainability and infrastructure. Town officials are coordinating with Capital Area Metropolitan Planning Organization (CAMPO) to consider proposals that include the U.S. 1 interchange, widening Friendship Road into a four-lane median-divided corridor, and adding bike lanes, roundabouts, and new access points. Other upgrades will address traffic, water usage, and public service needs. Genentech has pledged several environmental goals, including reducing its global footprint by half before the end of the decade and achieving net-zero emissions by 2050. No doubt Holly Springs residents will be attentive to community updates provided by the Town and watching closely as plans unfold.
Looking ahead, the new Genentech facility is more than an economic win for Holly Springs — it underscores the town’s growing reputation as a life sciences destination and represents a vision for the future. By bringing opportunity to local families, bolstering the business community in and around our town, and strengthening partnerships with educational institutions, Holly Springs takes its place firmly on the national map as a leader in advanced manufacturing and biotechnology.
